Although the Draft Guidelines provide guidance for stakeholders as to how the Act will be enforced, they do not adequately ensure that harms to mobile innovation and Japanese consumers will be minimized.

It is critical that, in tackling both these issues, the EU avoids engaging in digital protectionism, which would harm European competitiveness further.

The Center welcomes the European Commission’s ambition to accelerate the uptake of AI across the economy and public sector as part of its broader AI continent action plan.

The Center for Data Innovation urges the U.S. to refocus its federal AI R&D strategy on unlocking AI’s full potential by emphasizing deployment over harm prevention, linking technical design to real-world performance outcomes, and investing in the generation of high-quality, representative data to drive innovation and public benefit.

ITIF respectfully urges the FRA to approve the requested relief and to initiate broader regulatory modernization that embraces autonomous safety technologies.

While targeted rules and regulations which address real market failures and improve the status quo can be defensible, there are many that do not benefit competition or consumers and should likely be rescinded.

While targeted rules and regulations which address real market failures and improve the status quo can be defensible, there are many that do not benefit competition or consumers and should likely be rescinded.

The district court’s Order substantially risks disrupting the iOS ecosystem by sua sponte preventing Apple from exercising its right to charge what it wishes for the use of its platform. That is not behavior that was found to violate California’s UCL and for good reason: above cost pricing is per se lawful and an essential part of the market system upon which the antitrust laws are premised.

As part of its deregulation efforts, the administration should clarify Bayh-Dole march-in rights; rescind NIH Access Planning Policy; rescind FRA two-person train crew requirements; clarify requirements for manually operated driving controls; protect America’s innovative clean-energy technologies; and streamline regulatory permitting for semiconductors.

Instead of blanket tariffs, America should focus first on persuading other nations to pay their fair share, and then on supporting public-private investments in novel technologies that will make U.S. pharmaceutical producers more innovative and cost-competitive.